Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OHR Pharmaceutical Inc (NASDAQ:OHRP)

2.81
Delayed Data
As of 3:57pm ET
 +0.02 / +0.72%
Today’s Change
2.44
Today|||52-Week Range
6.56
-54.23%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$89.6M

Company Description

Ohr Pharmaceutical, Inc. is a pharmaceutical company, which focuses on the development of novel pharmaceuticals for the treatment of serious and unmet medical needs. Its products include Squalamine and Trodusquemine. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.

Contact Information

Ohr Pharmaceutical, Inc.
800 3rd Avenue
New York New York 10022
P:(212) 682-8452
Investor Relations:

Employees

Shareholders

Mutual fund holders3.83%
Individual stakeholders22.52%
Other institutional14.43%

Top Executives

Ira A. GreensteinChairman & Secretary
Jason Scott SlakterChief Executive Officer & Class II Director
Samuel I. BackenrothCFO & Principal Accounting Officer
Glenn L. StollerChief Scientific Officer
Avner IngermanChief Clinical Officer